SARINYAPINNGAM/iStock through Getty Pictures
Telix Prescribed drugs (OTCPK:TLPPF) is about to reinforce its North American manufacturing footprint and set up the premise of a “subsequent technology radiometal manufacturing community” by buying RLS, America’s solely Joint Fee-accredited radiopharmacy community, from its guardian firm, RLS Group Ltd., for $250M.
The acquisition